Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HU00701/HU007 Eye Drops in Dry Eye Syndrome
NCT02917512Phase 2Completed
- Sponsor
- Huons
- Start
- Mar 2016
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of cyclosporine + trehalose in dry eye syndrome (DED) (4 arms), sponsored by Huons. Primary endpoint: change from Baseline of Corneal staining score - Oxford grading at 12 weeks. Started Mar 2016; status: completed.
02
Drugs
cyclosporine + trehalose
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on NCT02917512.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02917512.